Abstract:AIM:To study the mechanism of absorption after oral administration of panaxnotoginseng saponins (PNS).METHODS:Caco-2 cells and rat models were applied to evaluate the degradation of both ginsenoside Rb1 (Rb1) and ginsenoside Rg1 (Rg1) in PNS in gastrointestinal lumen, and the transport mechanism of PNS across the intestinal mucosa, and the barrier function of stomach, intestine and liver involved in absorption process.RESULTS:Rb1 and Rg1 proved to be readily eliminated in stomach, but stable in relatively neutral circumstance. Both Rb1 and Rg1 in PNS, especially for Rb1, degraded significantly in the contents of large intestine. However, both of them kept mainly intact in the contents of small intestine. Uptake of both Rb1 and Rg1 by Caco-2 cell monolayer was inhibited at low temperature, but not by cyclosporine A, and the change in the apical pH showed no pronounced effect. Uptake and transport were non-saturable and increased linearly with increasing of concentrations of Rb1 and Rg1 over the range of concentration tested, which indicated a passive transport. There was no significant difference of absorption characteristic between monomer (Rb1 and Rg1) and mixture (PNS). Uptake amount of Rg1 [(1.07 +/- 0.16) microg x mg(-1) (protein)] (C0 = 1 mg x mL(-1)) in Caco-2 cells was a little higher than that of Rb1 [(0.77 +/- 0.03) microg x mg(-1) (protein)] (C0 = 1 mg x mL(-1)). Meanwhile, apparent permeability coefficient of (5.9 +/- 1.0) x 10(-8) cm x s(-1) (C0 = 1 mg x mL(-1)) for Rb1 and (2.59 +/- 0.17) x 10(-7) cm x s(-1) (C0 = 1 mg x mL(-1)) for Rg1 from apical compartment to basolateral compartment predicted an incompletely absorption. Transports of both Rb1 and Rg1 were not influenced by cyclosporine A. The investigation on the pharmacokinetic behavior of Rb1 and Rg1 after different routes of administration to rats showed that the absolute bioavailability after peroral (po), intraduodenal (id), and portal venous (pv) administration is 0.71% , 2.75% and 65.77% respectively for Rb1, and 3.29%, 6.60% and 50.56% respectively for Rg1.CONCLUSION:Transport across Caco-2 cell monolayer for PNS (include Rb1 and Rg1) is a simple passive diffusion process. No efflux transporters in Caco-2 cells and other components in PNS showed effects on it. The elimination in stomach, large intestine and liver contributed to the low bioavailability of PNS, but the low membrane permeability might be a more important factor dominating the extent of absorption.

Percutaneous absorption of Rg1 in Panax notoginseng in vitro

[Comparison Between the Characteristics of Absorption and Pharmacokinetic Behavior of Ginsenoside Rg1 and Ginsenoside Rb, of Panax Notoginseng Saponins].

Optimization of Transdermal Enhancers for Panax Notoginseng Saponins Cataplasm

Difference in Oral Absorption of Ginsenoside Rg 1 Between in Vitro and in Vivo Models

Evaluation of intestinal absorption of ginsenoside Rg1 incorporated in microemulison using parallel artificial membrane permeability assay.

Transport behavior and efflux of Rg1 in rat pulmonary epithelial cells.

Oral Absorption Of Ginsenoside Rb-1 Using In Vitro And In Vivo Models

In Vitro Evaluation of Panax Notoginseng Rg1 Released from Collagen/chitosan-Gelatin Microsphere Scaffolds for Angiogenesis

Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panaxnotoginseng in rats

[Mechanism of Oral Absorption of Panaxnotoginseng Saponins].

Effect of enzyme on extraction of ginsenoside Rb1 and Rg3 from Panax notoginseng roots

Study on preparation and transdermal drug delivery of saponins of panax notoginseng compound liposomal gel

Dermal Delivery of Korean Red Ginseng Extract: Impact on Storage Stability of Different Carrier Systems and Evaluation of Rg1 and Rb1 Skin Permeation Ex Vivo

Exploration of Tissue Distribution of Ginsenoside Rg1 by LC-MS/MS and Nanospray Desorption Electrospray Ionization Mass Spectrometry

A Comparative Study of Using In-Line Near-Infrared Spectra, Ultraviolet Spectra and Fused Spectra to Monitor Panax Notoginseng Adsorption Process.

Existing Forms of Notoginsenoside R1 in Rats and Their Potential Bioactivities.

Integrated metabolomic and transcriptomic analyses revealed the distribution of saponins in Panax notoginseng

The Melanogenesis-Inhibitory Effect and the Percutaneous Formulation of Ginsenoside Rb1

The Use of Lipid-Based Formulations to Increase the Oral Bioavailability of Panax Notoginseng Saponins Following a Single Oral Gavage to Rats

Pharmacokinetic and pharmacodynamic study of Panax notoginseng saponins nasal gel spray